STOP THE WAR! Let’s support Ukraine Together

The Latest SPAC News and Rumors: September 14, 2022


The Latest SPAC News and Rumors: September 14, 2022


Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News: Ambipar buys Witt O’Briens for $161.5M, SPAC winter spreads to Middle East with two deals delayed, and Wag! partners with Babylist

Brazil’s Ambipar buys Witt O’Briens in $161.5 mln deal

Brazilian environmental services provider Ambipar said on Wednesday it bought Witt O’Briens for an enterprise value of $161.5 million, pushing ahead with its global expansion.

The deal, made through its subsidiary Ambipar Response, marks the company’s entry into Asia and Oceania markets and strengthens its presence in the continents where it already operates, Ambipar said in a securities filing.

The acquisition takes place shortly before the completion of Ambipar Response’s tie-up with U.S. listed SPAC HPX Corp (NYSE:HPX), set to happen by the year’s end.

SPAC Winter Spreads to Middle East With Two Deals Delayed

Concerns over the blank-check industry are spreading to the Middle East, dealing a blow to the region’s SPAC market that barely got off the ground.


Babylist and Wag! Join Forces To Help Pet Parents Welcome Baby Home

Babylist, the leading vertical marketplace and commerce destination for baby, and Wag! (Nasdaq: PET), a platform for busy pet parents, offering access to five-star dog walking, pet sitting, expert pet advice, wellness plans, and one-on-one training from a community of local pet caregivers, are helping new parents make the transition of bringing home a new baby a little easier.


Levere SPAC’s Finance Chief Steps Down

Levere Holdings Corp. (NASDAQ:LVRA) said Tuesday that Stefan Krause, its chief financial officer and chief investment officer, intends to resign immediately.

The SPAC disclosed in a securities filing that Mr. Krause had given notice of his plans, and that the departure “was not a result of any disagreement with the company on any matter relating to its operations or its accounting or financial policies or procedures.”


LanzaTech CEO Highlights Company Role as a Synthetic Biology Leader at White House Event Celebrating Biotechnology

LanzaTech NZ, Inc., an innovative Carbon Capture and Transformation company that transforms waste carbon into materials such as sustainable fuels, fabrics, packaging and other products that people use in their daily lives, today announced that Dr. Jennifer Holmgren, CEO of LanzaTech participated in the Summit on Biotechnology & Biomanufacturing for the American Bioeconomy today at The White House.

As previously announced LanzaTech has entered into a merger agreement for a business combination transaction with AMCI Acquisition Corp. II (Nasdaq: AMCI).